Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other Accumulated Expenses (2022 - 2025)

Sanara MedTech's Other Accumulated Expenses history spans 4 years, with the latest figure at $235001.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $235001.0; the TTM value through Dec 2025 reached $235001.0, changed N/A, while the annual FY2025 figure was $235001.0, N/A changed from the prior year.
  • Other Accumulated Expenses reached $235001.0 in Q4 2025 per SMTI's latest filing, up from $228001.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.9 million in Q3 2024 to a low of $39659.0 in Q2 2025.
  • Average Other Accumulated Expenses over 4 years is $829412.2, with a median of $979488.0 recorded in 2024.
  • Peak YoY movement for Other Accumulated Expenses: soared 90.66% in 2024, then tumbled 96.35% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $1.2 million in 2022, then dropped by 5.41% to $1.1 million in 2023, then skyrocketed by 73.32% to $1.9 million in 2024, then plummeted by 87.67% to $235001.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Other Accumulated Expenses are $235001.0 (Q4 2025), $228001.0 (Q3 2025), and $39659.0 (Q2 2025).